Blog
Preclinical proof helps the superior effectiveness of sotagliflozin in attenuating salt-induced kidney harm
09
Nov
Nov
Sodium-glucose cotransporter 2 (SGLT2) inhibitors, initially developed to deal with kind 2 diabetes, believe important cardioprotective results. Within the kidney, SGLT2 reabsorbs roughly 97% of filtered glucose within the S1 and S2 segments of the proximal tubule, whereas SGLT1 reabsorbs the rest within the S3 section. In research in rats, researchers discovered that twin inhibition […]